Antioxidant/Cancer Disease Claims Prompt FDA Letters
This article was originally published in The Tan Sheet
Executive Summary
Cancer claims for Chemron's Sun Ginseng are misbranded due to labeling shortcomings, FDA says in a recent courtesy letter to the company
You may also be interested in...
USDA Retracts Statement Barring OTCs, Supplements From Organics Program
The USDA Agricultural Marketing Service will retract a recent statement clarifying that dietary supplements and OTCs cannot be certified under the National Organic Program, according to the agency
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands